Aspirin as Anticoagulant Therapy in Children After Surgical Repair of Complex Congenital Heart Defects – Kosovo Experience

Abstract

Background. The most often identified congenital condition affecting infants is congenital heart disease (CHD), which affects 0.8% to 1.2% of live births globally. In general, congenital heart defects are heart structural abnormalities, (or) great vessels that are present at birth. Children with untreated congenital cardiac defects are perpetually hypoxic, have a lower quality of life, and have shorter lifespans.

 Objectives. The purpose of the presentation is to highlight the importance of red blood cells, hemoglobin, and hematocrit and the outcomes of antithrombotic medication administered to kids who had Glenn or Fontan palliation.

Methods. In the years 2021 to 2022, we looked at samples of 40 children from various Kosovo regions who had a complex CHD, diagnosed in the postnatal period.

Results. There were 40 kids with complex CHD, one form of palliative intervention, such as Glenn or Fontan, has been carried out in each of them. Surgery has been performed in various European nations, the USA, and Turkey as a result of the lack of heart surgical services in Kosovo. After undergoing cardiac surgical procedures, we measured the red blood cell, hemoglobin, and hematocrit levels in children with complex CDH using Aspirin and compared the results to 30 healthy children.

Conclusion. In complex CHD cases, Glenn and Fontan palliations surgeries are the preferred approaches. There are numerous clinical and laboratory indications of complications after intervention. These youngsters require very sophisticated assessment and follow-up, which typically requires a multifaceted approach.